International Cancer Cluster Showcase (ICCS 2022) 
 ​
Join ICCS 2022 to learn about emerging oncology innovators from the U.S. and Europe.
ICCS 2022 is being presented digitally via a Digital Brochure - see blue button above. 
This brochure offers a flexible format highlighting oncology innovators from American and European innovation hubs.  

If you are interested in a particular company and would like to learn more about other technologies and assets developed in the partner regions, you can reach out for an introduction or a Zoom meeting (see contact information in the Digital Brochure).

About ICCS and BIO. Since 2013, 200+ representatives from the international oncology community have joined and actively participated at ICCS each year.  ICCS has traditionally been a satellite event to BIO where partners team up to highlight recent innovations from their regions.  In 2022, ICCS will be presented via a digital brochure.  

ICCS 2023 will be planned as an on-site event in Boston, where ICCS started in 2012.
Portfolios of previous ICCS events may be found at  ICCS ARCHIVE
About the ICCS Digital Brochure.

  • Provides an opportunity to learn more about emerging start-ups, novel licensing opportunities, promising clinical trial results, and innovative technology platforms.
  • Gives an overview to connect and work with the clusters and regions involved.
Who could benefit the ICCS Digital Brochure?

  • Scouting, Business Development and Licensing Executives from international Pharma and Biotech
  • Representatives from Biopharma's Venture Funds
  • Venture Capitalists
  • Oncology focused Biotechs
  • Researchers and clinicians focusing on oncology R&D
  • Tech Transfer Offices
ICCS 2022 sponsors are to be confirmed.  ICCS 2021 was sponsored by:
Organizers: